These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Experimental drug-induced changes in renal function and biodistribution of 99mTc-MDP. McAfee JG, Singh A, Roskopf M, Ritter C, Lyons B, Schoonmaker JE, Thomas FD, Jones D. Invest Radiol; 1983; 18(5):470-8. PubMed ID: 6227584 [Abstract] [Full Text] [Related]
34. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging? Kumar V, Kumar D, Howman-Giles RB, Little DG. Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350 [Abstract] [Full Text] [Related]
35. The uptake of 99mtechnetium diphosphonate into degenerating and regenerating muscle. A correlative histological and biochemical study. Vita G, Harris JB. J Neurol Sci; 1981 Sep; 51(3):339-54. PubMed ID: 6456331 [Abstract] [Full Text] [Related]
36. Changes in renal uptake of Tc-99m methylene diphosphonate (MDP) in stone-forming rats. McAfee JG, Thomas FD, Roskopf M, Ritter K, Lyons B, Lilien OM, Schoonmaker JE. Invest Radiol; 1984 Sep; 19(6):543-8. PubMed ID: 6239838 [Abstract] [Full Text] [Related]
37. Technetium-99m methylene diphosphonate accumulation in the diaphragm after severe ischemia. Howman-Giles R, Rahilly PM. Clin Nucl Med; 1983 Sep; 8(9):416-7. PubMed ID: 6227441 [No Abstract] [Full Text] [Related]
38. 99mTc-methylene diphosphonate accumulation in ascitic fluid due to neoplasm. Gordon L, Schabel SI, Holland RD, Cooper JF. Radiology; 1981 Jun; 139(3):699-702. PubMed ID: 6453357 [No Abstract] [Full Text] [Related]